Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(1012)
•••
Comment by investclubon Apr 11, 2020 2:01pm
73 Views
Post# 30899158

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SCARY TIMES!!

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SCARY TIMES!!skier59 what makes you think this week we will see a NR is it gut feeling or have you heard something from a reliable source?  I hope you've had contact with Theralase! 


skier59 wrote

   Don't worry Bunge, we will have some TLT news this week to talk about very soon. Life right now is very boring for me because I can't spend time with my girlfriend. I have just had way too much fun getting skyhawk1 all pumped up and barking like a rabid dog. I've posted enough about Humpy Dumpy Trumpy for now.

Now what is this I'm reading about HCQ;
Besides all these side effects mentioned below, apparently because it suppresses ones immune system, it might make you susceptible to getting the virus again because your body did not learn to clean it out on the first attempt. Oh and to all of those who were saying that for sure Chris Cuomo got the HCQ treatment, no he decided not to take it and let his body fight the virus.
Common hydroxychloroquine side effects may include:
  • headache, dizziness, ringing in your ears;
  • nausea, vomiting, stomach pain;
  • loss of appetite, weight loss;
  • mood changes, feeling nervous or irritable;
  • skin rash or itching; or.
  • hair loss.
Mar 17, 2019
 


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities